Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma

Glioblastoma (GBM) is the most common malignant adult brain tumor that is resistant to the standard care therapy. Advances in chimeric antigen receptor (CAR) T cell therapies have spurred renewed interest in developing CAR T cell therapies to target chemoradiotherapy-resistant brain tumor-initiating...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:STAR Protoc
Päätekijät: Tatari, Nazanin, Maich, William T., Salim, Sabra K., Mckenna, Dillon, Venugopal, Chitra, Singh, Sheila
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757398/
https://ncbi.nlm.nih.gov/pubmed/33377068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xpro.2020.100174
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia